That is necessary, because the way a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and work. In other words, we have to understand how these proteins fold if we want a drug to work. Historically, this has actually been an experimental process (brownstone research). However now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much easier to create drugs that do what they're designed to do. This was a development almost no one noticed. But it's going to have extensive ramifications for treating illness. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, of course, there will be lots of investment chances in this space, too. Moving subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (legacy report prediction). That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be surprised if it drew back maybe considerably before going higher - first lady. I've been covering bitcoin for a very long time now. Among the very first research study reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary recommendation, I entitled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were primarily educating readers. But that's not the huge question any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. Mass, Mutual is a trusted 170-year-old institution. So think about that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a huge factor I'm bullish on it this year. jeff brown. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are many excellent personal business on the brink of striking the general public markets And I've been working on a new way for you to invest even before these companies go public.
This opportunity has actually been developing over the last few years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover out all the information. Go right here to schedule your spot totally free.
Emma Walsh here, handling editor of the Journal. Regular Diary readers know that tech isn't our usual beat (jeff brown tech stock 2021). And when it concerns tech investing, we leave it to the professionals. The good news is, we have several such experts in our Rolodex. Our coworker Jeff Brown will be familiar to our long time readers. He is one of the most accomplished tech investing professionals we understand (exponential tech investor). In truth, he had several triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the huge photo and anticipate what's just around the corner.
That consists of things like 5G networks, biotech, synthetic intelligence, and far more. These patterns are experiencing rapid growth and creating incredible chances for investors. I desire to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the picture of what I see can be found in the next 12 months Our new 5G (fifth-generation) cordless networks are a subject I've been covering for years now. jeff brown genetic sequencer stock. But regardless of what lots of readers may think, this is a pattern that's just beginning. Despite the fact that the COVID-19 pandemic interrupted supply chains last year, an excellent 250 million 5G-enabled devices were still sold.
And all of this eventually caused Apple delaying the release of the 5G-enabled i, Phone 12 by two months (second wave). Losing 2 months of manufacturing and sales really affects how numerous 5G devices are offered in the calendar year. When you think about all of that, selling 250 million units is exceptional. More importantly, the delays triggered by the pandemic produced a load of pent-up demand. And that need is now going to be pushed into 2021. In fact, I predict that more than 500 million 5G devices will be delivered in 2021 - democratic republic. Which's not my only 5G forecast When I have actually spoken about 5G in the past, I've explained its 3 different phases.
In Stage Two, 5G devices go on sale. 5G phones and other products start to reach consumers. And in Stage 3, 5G services start to be provided (jeff brown investment prediction). That's when we begin to see applications working on 5G networks. Think about things like massive multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will begin Phase 3 by this summer season. This begins something of a virtuous cycle: Many individuals do not really appreciate the innovation. But they will care if there are exciting applications that can only be accessed with a 5G phone.
That leads to more 5G apps being developed. In reality, 5G is going to open a suite of amazing applications: self-driving cars, the Internet of Things, robotic surgical treatment, and more. All of these technologies need 5G. The investment opportunities going forward will be enormous. Stepping away from 5G, the next important technology I visualize in 2021 is CRISPR genetic modifying. CRISPR means "clustered regularly interspaced brief palindromic repeat." It's a mouthful. But it is among the most amazing developments in biotechnology. At a high level, CRISPR is an innovation that can modify our genetic makeup as if it were software application.
The program can crash or not operate properly. CRISPR uses a similar idea but with our genetic code. "Typos" in our genome can result in illness. CRISPR can remedy these "typos." For many years, CRISPR was mainly a specific niche innovation that wasn't well comprehended. And during that time, there were truly just three business operating in this area. However things are altering. CRISPR is no longer just theoretical. We're seeing actual results. We're dealing with illness and seeing that this technology simply works. And as a result, a "2nd crop" of early-stage CRISPR companies is going public and delivering extraordinary returns. This entire industry is effectively a greenfield opportunity.
There's space for many business to exist in this space. future report review. And there will be more. That's my prediction for CRISPR in 2021. I anticipate that 2 or 3 more hereditary editing companies will hold their IPOs. Sticking to biotechnology, we are seeing incredible things occurring at the merging of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its newest Alpha, Fold software can precisely predict the folding of a protein based solely on its amino acid sequence with 92. 4% precision. That's important due to the fact that the method a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and work.
Historically, this has actually been an experimental procedure. Today, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much simpler to develop drugs that do what they're created to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one however numerous drug therapies produced utilizing this innovation. This was one of those developments that practically nobody saw. But it's going to have extensive implications for treating illness. And, naturally, there will be plenty of investment opportunities in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be amazed if it drew back perhaps significantly before going higher. I have actually been covering bitcoin for a very long time now. One of the first research reports I ever released was on bitcoin - jeff brown prediction. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for any person who followed my suggestion. However at the time of that preliminary recommendation, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time.
However nobody is asking that concern anymore. Now, we're seeing institutional money finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. jeff brown stock predictions. Mass, Mutual is a 150-year-old organization. So think of that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus offer forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and claims the details depends on date as of February 2021, but we might not individually validate this claim. Offered Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down an exact figure at this minute. Brown is best known for his sage-like ability to choose winning innovation stocks. He spent more than 25 years researching innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an exceptional perspective on the market. He's constantly on the hunt for brand-new chances, and he shares much of his best picks in the Near Future Report.
That's full marks, however it's not ridiculously reasoned. Brown has an outstanding credibility as a stock-picker, and he successfully anticipated some of the greatest financial occasions of the past twenty years. Although he doesn't appear to launch his picks to the public, the service's success is a direct sign of Brown's stock-picking prowess. Nobody on Wall Street gets it right whenever, however Jeff Brown's accurate predictions have actually made him legions of dedicated fans. That says a lot about his capability. The Near Future Report is published by Brownstone Research study, a popular financial research study publisher. Brownstone Research study provides a number of research services with a broad range of expertises - tech stocks.
The company is likewise associated with Bonner & Partners, another well-respected research study publisher - the legacy report predictions. On its website, Brownstone states its objective is to provide retail investors with professional-grade research study: "For too long, the very best investment research has actually not been available to individual financiers. It has been typically reserved for financial investment banks, hedge funds, private equity, and high-net-worth customers. jeff brown biotech stock pick for 2020. The objective of Brownstone Research study is to make that sort of proprietary research offered to any financiers looking to gain an edge in the markets. The goal is basic to deliver special and successful investment research study discovered nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research, and he likewise functions as the firm's Chief Investment Expert.
With Brown assisting the ship, Brownstone Research is a powerhouse publisher with lots to provide its customers. After decades of constant success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a home name throughout many of America. If you know even a bit about the market, you know that he has a track record as a King Midas of sorts. jeff brown top stock pick 2021. Whatever he touches relies on gold! Jeff is well aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge project.
In truth, Brown thinks S.A.V. korean actress. might be "the biggest trend of the 2020s, and he's not alone. Inspect out these quotes from other widely known S.A.V. bulls: Elon's next huge act will be marrying two cutting-edge innovations: expert system and electric cars. Musk hopes the combination will help him develop the first fully-autonomous, self-driving cars and trucks ever. It's absolutely nothing except the automobile industry's Holy Grail. As you understand, electric cars and self-driving vehicle stocks have actually been substantial this year, however the Wall Street machine has actually been huge on buzz without much concrete outcome. In spite of an extreme boost in competitors over the previous couple of years, Brown still thinks Musk has the best chance of putting everything together.
tech might be the magic string that ties all of it together. S.A.V. represents Shared Autonomous Automobile, and it might be the future of transportation. Generally, this innovation would allow you to lease your car as an autonomous, self-driving taxi when you're not using it. You merely get out of the vehicle and press a button on an app that informs the vehicle to "sign up with the fleet." Next thing you understand, you're unwinding on your sofa while your car shuttles ride-sharers around town. Best of all, you get to keep a large piece of the earnings. It sounds insane, but it could be closed than you believe.